Johnson & Johnson (NYSE:JNJ)

Goldman Sachs and More Dow Earnings Kicking Off Tuesday

When 2016 came to a close, analysts were predicting that the Dow Jones Industrial Average would end 2017 at 22,000. At least this is what the more bullish analysts were ...
Read Full Story »

Goldman Sachs, GE, Verizon and More Dow Stocks Reporting This Week

24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results this week. Overall, seven companies in the Dow are ...
Read Full Story »

Walmart, Johnson & Johnson Lift DJIA Wednesday

October 11, 2017: Markets opened mixed Wednesday and trading was choppy during the first couple of hours before settling on an up-and-to-the-right trend. The leading sectors were real estate and ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Facebook, Johnson & Johnson, Schlumberger, Visa, Walmart and More

Stocks were indicated to open marginally lower on Wednesday morning, but that is after the Dow hit new all-time highs on Tuesday and has come within 170 points of hitting ...
Read Full Story »

Deutsche Bank Adds 5 Large Cap Leaders to Conviction List

With the last quarter of 2017 underway, and a rash of third-quarter earnings ready to hit the tape, many of the top firms we cover here at 24/7 Wall St. ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Ctrip, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan Stanley, Yelp, Yum China and More

Stocks were indicated to open higher on Monday morning, partly led by overseas markets and a gain in China. The S&P 500 and Dow Jones Industrial Average hit all-time highs ...
Read Full Story »

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. The firm is looking at pharma and biotech opportunities around politics, drug pipelines and ...
Read Full Story »

Major Biotech, Pharma and FDA Catalysts Coming in October

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More

Stocks were looking for direction on Monday morning after hitting all-time highs last week. The primary trend that has dominated this eight-year bull market is that investors keep finding new ...
Read Full Story »

Apple, Procter & Gamble Sink the DJIA Thursday

September 21, 2017: Markets opened lower Thursday while equities traders try to read the FOMC tea leaves for a rate hike by the end of this year. The Fed will ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Biogen, Electronic Arts, Gap, Intuit, J&J, 3M, Intercept, AutoZone and More

Stocks were looking for direction on Wednesday, but this after the major indexes have all hit fresh all-time highs. The one trend that has dominated this bull market is that ...
Read Full Story »

Why Pfizer Is Pushing the Dow to All-Time Highs

Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on the day. In fact, Pfizer Inc. (NYSE: PFE), Merck & ...
Read Full Story »

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Merrill Lynch recently released its September RIC Report, noting key strategy views and showing many sector views. One such view from the firm was that health care stocks are currently ...
Read Full Story »

Achillion Pharma Slides After Hep C Deal Is Terminated

Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) saw its shares slump early on Monday after the firm announced that its hepatitis C license and collaboration agreement with Janssen had been terminated. The ...
Read Full Story »

Johnson & Johnson, Disney Lead DJIA Lower Wednesday

August 23, 2017: Markets opened lower Wednesday and trading on all three major indexes remained in the red all day. A comment from President Trump last night regarding a government ...
Read Full Story »